HealthEquity (NASDAQ:HQY) PT Raised to $103.00 at Deutsche Bank Aktiengesellschaft

HealthEquity (NASDAQ:HQY) had its price target raised by Deutsche Bank Aktiengesellschaft from $102.00 to $103.00 in a research report sent to investors on Wednesday, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

Several other equities analysts have also recently weighed in on the stock. Raymond James increased their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an outperform rating in a research note on Friday, June 7th. Bank of America dropped their price target on shares of HealthEquity from $105.00 to $100.00 and set a buy rating on the stock in a research note on Wednesday. JMP Securities restated a market outperform rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday. KeyCorp lifted their target price on HealthEquity from $95.00 to $100.00 and gave the company an overweight rating in a research report on Wednesday, June 5th. Finally, Wells Fargo & Company upped their price target on HealthEquity from $107.00 to $110.00 and gave the stock an overweight rating in a research report on Thursday, June 20th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of Moderate Buy and an average target price of $103.83.

HealthEquity Price Performance

NASDAQ HQY opened at $82.66 on Wednesday. The stock has a market capitalization of $7.19 billion, a price-to-earnings ratio of 89.85, a PEG ratio of 1.34 and a beta of 0.52. HealthEquity has a 1-year low of $61.81 and a 1-year high of $88.26. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.39 and a quick ratio of 4.39. The business’s fifty day moving average price is $77.32 and its 200-day moving average price is $79.70.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, June 3rd. The company reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.08. The company had revenue of $287.60 million for the quarter, compared to the consensus estimate of $278.78 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. On average, equities analysts predict that HealthEquity will post 2.12 earnings per share for the current year.

Insider Activity at HealthEquity

In other news, Vice Chairman Stephen Neeleman sold 2,080 shares of the business’s stock in a transaction on Friday, June 7th. The shares were sold at an average price of $85.01, for a total value of $176,820.80. Following the transaction, the insider now owns 90,515 shares of the company’s stock, valued at $7,694,680.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, Vice Chairman Stephen Neeleman sold 2,080 shares of the firm’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $85.01, for a total transaction of $176,820.80. Following the completion of the transaction, the insider now owns 90,515 shares in the company, valued at $7,694,680.15. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Jon Kessler sold 32,326 shares of the business’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the sale, the chief executive officer now owns 232,176 shares in the company, valued at $19,231,138.08. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 77,111 shares of company stock valued at $6,280,446. 2.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Motley Fool Asset Management LLC raised its stake in HealthEquity by 3,001.0% during the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after purchasing an additional 3,640,748 shares in the last quarter. Norges Bank purchased a new stake in shares of HealthEquity during the 4th quarter valued at about $43,482,000. Vaughan Nelson Investment Management L.P. bought a new position in shares of HealthEquity in the 1st quarter valued at about $49,443,000. Wasatch Advisors LP lifted its holdings in shares of HealthEquity by 8.3% in the 1st quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after acquiring an additional 569,249 shares during the last quarter. Finally, Mackenzie Financial Corp grew its position in HealthEquity by 16.0% in the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after acquiring an additional 325,906 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.